Assess Your Cardiovascular Health Risk:
Advanced Lipid Markers with Optional Genomic Markers
Available to everyone throughout UK, Ireland and rest of Europe, order your test kit below.
Why Use the CV Health Plus Genomics Profile?
CV Health Plus Genomics is a cardiovascular risk assessment that analyzes lipid biomarkers and genomic risk factors associated with cardiovascular disease (CVD) and helps assess your risk for heart disease. Traditional lipid markers (such as LDL cholesterol, HDL cholesterol and triglycerides) while informative, do not fully account for individual cardiovascular risk
The CV Health Profile assesses a combination of standard lipid markers and advanced biomarkers that provide information on cholesterol metabolism, inflammation, and insulin resistance.
The CV Health Plus Genomics Profile analyzes for the above in addition to DNA mutations known as single nucleotide polymorphisms (SNPs) in four select genes related to cardiovascular health and blood clotting. With this genomic insight and biomarker information, it is possible to create highly personalized, targeted interventions that address specific metabolic areas to help minimize risk and support improved cardiovascular health.
Who might benefit from CV Health with/without genomics:
CV Health Plus Genomics can help identify individuals at risk for cardiovascular disease and allow for monitoring of previously abnormal results.
CV Health Profile may be appropriate for you if any of the following apply:
About the CV Health Plus Genomics Profile
Colour-coded graphics, the CV Health Plus Genomics report synthesizes test results into an easy-to-interpret reporting format. Genomic results are reported with accompanying information on health implications and treatment options.
CV Health Plus Genomics offers an innovative assessment featuring an advanced lipid profile using Nuclear Magnetic Resonance (NMR) fractionation technology, inflammatory biomarkers, and a novel Insulin Resistance Score. In addition, this profile includes analysis for single nucleotide polymorphisms (SNPs) in four select genes related to cardiovascular health and blood coagulation.
Both Cardiovascular Health profiles evaluate:
CV Health Plus Genomics™ offers all biomarkers listed above plus the additional analyses of single nucleotide polymorphisms (SNPs) in four select genes related to cardiovascular health and blood coagulation:
Traditionally assessed risk factors do not fully account for the development of cardiovascular disease, the number one cause of death in the US. The CV Health profiles offer a comprehensive evaluation featuring an advanced lipid profile that utilizes Nuclear Magnetic Resonance (NMR) fractionation technology, inflammatory markers, and a novel Insulin Resistance Score. These advanced biomarkers provide insight into metabolic areas associated with CVD risk, significantly increasing diagnostic yield. In addition, the genomics option provides insight into genetic predispositions that may increase risk for the development of cardiovascular disease.
Test Details:
Laboratory:
Test name(s):
Specimen Requirements:
|
|
|
Costs - Accurate at May 2021:
Lab Analysis Fees:
Please note that blood draw fees and shipping are payable in addition to above test analysis fees
£12 UK; £23 other countries.
Order your Test Below
Please complete details below to order a test kit for the CV Health™ or CV Health Plus Genomics™. Test kits include full instructions. You will be invoiced for the test via email prior to test kit being sent out to you.